Skip to content
Hair Pipeline
← Recruiting trials
NCT01669746Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)

A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of ex Vivo-cultured, Expanded, Occipital Autologous Dermal and Epidermal Cells, Injected Into the Hair Loss Area of the Scalp of Male and Female Subjects With Alopecia

In the register

The register attaches this trial to Aderans dermal sheath cup cells (Ji Gami) (Aderans Research Institute), currently at “Discontinued” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.

What the registry records

Status
Completed
Declared phase
Phase 2
Sponsor
Aderans Research Institute
Participants (registry)
34
Start
June 2012
Primary completion
April 2013
Study completion
—
Last registry update
July 2013
Countries
United States

Conditions studied: Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Baldness

Interventions: Autologous cultured mixed population of dermal cells

Full record on ClinicalTrials.gov ↗

Other trials of Aderans dermal sheath cup cells (Ji Gami)

  • NCT01451190Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)

  • NCT01451151Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)

  • NCT01451138Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)

  • NCT01451177Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)

  • NCT01451125Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)

  • NCT01451112Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)

  • NCT01451047Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)

  • NCT01451099Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss

  • NCT01451073Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)

  • NCT01451021Phase 2Completed

    A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.